biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by BearDownAZon Dec 21, 2015 11:54am

145 Views

Post# 24401301

RE:RE:RE:RE:HOLD THE FCK UP HERE FOR A MINUTE!!!!!!!!

Regardless,

I was the one who posted the first version that I saw, both on here and Agoracom. You didn't misread anything. The following sentence was a new addition added after the version I posted:

"From all of us at biOasis, we wish you and your families a very merry Christmas and, I know what will be a prosperous new year."

Nice catch.

BearDownAZ

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale